These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7952)

  • 41. Treatment of acute arrhythmias with orally administered tolamolol.
    Aronow WS; Johnson LL; Vangrove JS; Nelson WH; Khurseed M; Harding PR
    Chest; 1973 Jun; 63(6):917-21. PubMed ID: 4145819
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular effects of local adrenaline infiltration during neurolept analgesia and adrenergic beta-receptor blockade in man.
    Pöntinen PJ
    Acta Anaesthesiol Scand; 1978; 22(2):145-53. PubMed ID: 26160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
    Wariishi S; Yamashita K; Nishimori H; Fukutomi T; Yamamoto M; Radhakrishnan G; Sasaguri S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):811-3. PubMed ID: 19666952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapy of postoperative arrhythmias (author's transl)].
    Vormittag E
    Wien Klin Wochenschr; 1979 Apr; 91(8):267-71. PubMed ID: 88135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias.
    Nademanee K; Schleman MM; Singh BN; Morganroth J; Reid PR; Stritar JA
    Am Heart J; 1984 Oct; 108(4 Pt 2):1109-15. PubMed ID: 6207720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effects of tolamolol and propranolol on cardiac and peripheral circulatory function in patients with coronary artery disease.
    Miller RR; Vismara LA; Mason DT
    Clin Pharmacol Ther; 1975 Jun; 17(6):713-21. PubMed ID: 1095282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Practolol (I.C.I. 50172), a beta-adrenergic receptor blocking agent, in the management of cardiac arrhythmias.
    Vohra JK; Dowling JT; Sloman G
    Med J Aust; 1970 Aug; 2(5):228-31. PubMed ID: 4393952
    [No Abstract]   [Full Text] [Related]  

  • 50. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute and chronic effects of an adrenergic beta-receptor blocking agent (propranolol) in treatment of cardiac arrhythmias.
    Luria MH; Adelson EI; Miller AJ
    Circulation; 1966 Nov; 34(5):767-73. PubMed ID: 5923841
    [No Abstract]   [Full Text] [Related]  

  • 52. LB-46, a new beta-adrenergic receptor blocking agent in cardiac arrhythmias.
    Storstein L
    Acta Med Scand; 1972 May; 191(5):423-8. PubMed ID: 4402323
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetic and pharmacological studies with tolamolol in man.
    Faulkner JK; Stopher DA; Walden R
    Br J Clin Pharmacol; 1975 Oct; 2(5):423-8. PubMed ID: 786354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
    Mert KU; Mert GÖ; Morrad B; Tahmazov S; Mutlu F; Çavuşoglu Y
    Kardiol Pol; 2017; 75(8):786-793. PubMed ID: 28541596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 56. THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS.
    Tsetskhladze E; Khintibidze I
    Georgian Med News; 2017 Jun; (267):53-57. PubMed ID: 28726654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative anti-arrhythmic efficacy of mexiletine, procainamide and tolamolol in patients with symptomatic ventricular arrhythmias.
    Jewitt DE; Jackson G; McComish M
    Postgrad Med J; 1977; 53 Suppl 1():158-62. PubMed ID: 327454
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of alprenolol in acute cardiac arrhythmias.
    Lemberg L; Arcebal AG; Castellanos A; Slavin D
    Am J Cardiol; 1972 Jul; 30(1):77-81. PubMed ID: 4402503
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of atrial arrhythmias with alprenolol.
    Kerber RE; Goldman RH; Gianelly RE; Harrison DC
    JAMA; 1970 Dec; 214(10):1849-54. PubMed ID: 4396218
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative efficacy and tolerance of esmolol to propranolol for control of supraventricular tachyarrhythmia.
    Morganroth J; Horowitz LN; Anderson J; Turlapaty P
    Am J Cardiol; 1985 Oct; 56(11):33F-39F. PubMed ID: 2864847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.